Article
Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma
6 Nov 2019
Abstract excerpt
Pancreatic ductal adenocarcinoma (PAAD) is one of the most common malignant tumors in digestive system. To find the new therapeutic targets and explore potential mechanisms underlying PAAD, the bioinformatics has been performed in our study. The PAAD gene expression profile GSE28735 was chosen to analyze the differentially expressed genes (DEGs) between PAAD carcinoma tissues and normal adjacent tissues from 45...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
